BPR-30221616 injection

· Chengdu Brilliant Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPR-30221616 injection, covering 2025-02-12 to 2025-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Tolerability Study of BPR-30221616 Injection in Healthy Subjects [Phase 1]